---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015893"
form_type: "8-K/A"
ticker: null
cik: "0001476963"
company_name: "Scorpius Holdings, Inc."
filed_at: "2023-09-20T23:59:59+00:00"
generated_at: "2026-06-10T11:57:50.931502+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NightHawk Biosciences cuts 13 employees (14% workforce) in restructuring, refocuses on CDMO

## Summary
- Board approved restructuring plan on Sept 18, 2023 to shed non-core assets and reduce costs.
- Workforce reduction of 13 R&D employees; expects $0.2M-$0.3M in charges in Q3 2023.
- Annual compensation savings estimated at $1.8M from the workforce reduction.
- Company will refocus resources on Scorpius Biomanufacturing (CDMO) for growth.

## SEC filing metadata
- accession: 0001558370-23-015893
- form_type: 8-K/A
- cik: 0001476963
- company_name: Scorpius Holdings, Inc.
- filed_at: 2023-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1476963/000155837023015893/0001558370-23-015893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1476963/000155837023015893/nhwk-20230919x8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015893
- JSON: https://secwatch.observer/filing/0001558370-23-015893.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015893.txt

## Key facts
- Restructurings & Charges
  Scorpius Holdings, Inc. announced a restructuring with charges of approximately $0.2 million to $0.3 million affecting research and development efforts (approximately 13 employees).
  - Type: restructuring
  - Charge: approximately $0.2 million to $0.3 million
  - Affected area: research and development efforts
  - Headcount: approximately 13 employees
  source text: research and development efforts. The Company expects to substantially complete the employee reduction immediately and estimates that it will incur a total of approximately $0.2 million to $0.3 million in charges in connection with the workforce reduction, all of which is expected to be incurred in the third quarter of 2023. These charges consist primarily of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1476963/000155837023015893/0001558370-23-015893-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.